De Novo · Anesthesiology

ScanNav Anatomy Peripheral Nerve Block

by Intelligent Ultrasound Limited

ScanNav Anatomy Peripheral Nerve Block is an AI-enabled medical device from Intelligent Ultrasound Limited that the U.S. FDA granted through De Novo DEN220024 on October 18, 2022. Its lead review panel is Anesthesiology and its primary product code is QRG (Ultrasound Guided Nerve Block Assist).

See also all FDA AI clearances in 2022, top anesthesiology AI devices.

Key facts

Submission numberDEN220024
PathwayDe Novo
Date of final decision
Company (FDA list)Intelligent Ultrasound Limited
Lead review panelAnesthesiology
Primary product codeQRG — Ultrasound Guided Nerve Block Assist
Applicant (openFDA)Intelligent Ultrasound Limited
Applicant locationCardiff, GB
Device classClass 2
Regulation number21 CFR 868.1980
Decision codeDENG
Submission typeDirect

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

De Novo is the pathway for novel low-to-moderate-risk devices with no predicate. A granted De Novo creates a new device classification that later devices can use as a predicate. ScanNav Anatomy Peripheral Nerve Block went through this pathway (DEN220024).

openFDA lists it as a Class 2 device under 21 CFR 868.1980. Class II devices are moderate risk and are subject to general and special controls.

Product code QRG covers 3 devices on the FDA AI list. By decision date, this device is #1 of 3 under that code. Intelligent Ultrasound Limited has 2 AI-enabled devices on the list, and the Anesthesiology panel accounts for 30 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code QRG)

More from Intelligent Ultrasound Limited